SBI Securities »

Biodexa Pharmaceuticals shares owned by SBI Securities

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Biodexa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $84 29 2.90
2026-03-31 $93 151 0.62

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Apple (AAPL)
Micron Technology (MU)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Direxion Daily Semi Bull 3X ETF Etf (SOXL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)

View all positions for SBI Securities

Top funds holding Biodexa Pharmaceuticals

Armistice Capital
GAMMA Investing
Allied Private Wealth
SBI Securities
UBS Group
Hilton Head Capital Partners
Caitong International Asset Management

View all funds holding Biodexa Pharmaceuticals